Royal Bank of Canada’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
341,419
+336,435
| +6,750% | +$1.11M | ﹤0.01% | 3489 |
|
|
2025
Q1 | $15K | Sell |
4,984
-2,216
| -31% | -$6.67K | ﹤0.01% | 5620 |
|
|
2024
Q4 | $26K | Sell |
7,200
-3,125
| -30% | -$11.3K | ﹤0.01% | 5504 |
|
|
2024
Q3 | $51K | Buy |
10,325
+3,340
| +48% | +$16.5K | ﹤0.01% | 5225 |
|
|
2024
Q2 | $18K | Sell |
6,985
-23,015
| -77% | -$59.3K | ﹤0.01% | 5717 |
|
|
2024
Q1 | $128K | Buy |
+30,000
| New | +$128K | ﹤0.01% | 4608 |
|
|
2023
Q3 | – | Sell |
-4,000
| Closed | -$7K | – | 6543 |
|
|
2023
Q2 | $7K | Buy |
+4,000
| New | +$7K | ﹤0.01% | 6102 |
|
|
2022
Q4 | – | Sell |
-20,087
| Closed | -$23K | – | 6712 |
|
|
2022
Q3 | $23K | Buy |
+20,087
| New | +$23K | ﹤0.01% | 5591 |
|
|
2022
Q2 | – | Sell |
-1,600
| Closed | -$4K | – | 6866 |
|
|
2022
Q1 | $4K | Sell |
1,600
-2,330
| -59% | -$5.83K | ﹤0.01% | 6812 |
|
|
2021
Q4 | $15K | Buy |
3,930
+1,330
| +51% | +$5.08K | ﹤0.01% | 6372 |
|
|
2021
Q3 | $11K | Sell |
2,600
-4,674
| -64% | -$19.8K | ﹤0.01% | 6398 |
|
|
2021
Q2 | $29K | Buy |
7,274
+2,585
| +55% | +$10.3K | ﹤0.01% | 5857 |
|
|
2021
Q1 | $25K | Buy |
4,689
+1,905
| +68% | +$10.2K | ﹤0.01% | 5796 |
|
|
2020
Q4 | $15K | Buy |
2,784
+648
| +30% | +$3.49K | ﹤0.01% | 5633 |
|
|
2020
Q3 | $10K | Buy |
2,136
+536
| +34% | +$2.51K | ﹤0.01% | 5428 |
|
|
2020
Q2 | $8K | Sell |
1,600
-11,969
| -88% | -$59.8K | ﹤0.01% | 5419 |
|
|
2020
Q1 | $29K | Sell |
13,569
-27,408
| -67% | -$58.6K | ﹤0.01% | 4907 |
|
|
2019
Q4 | $239K | Buy |
40,977
+11,485
| +39% | +$67K | ﹤0.01% | 3943 |
|
|
2019
Q3 | $94K | Sell |
29,492
-29,817
| -50% | -$95K | ﹤0.01% | 4248 |
|
|
2019
Q2 | $249K | Buy |
+59,309
| New | +$249K | ﹤0.01% | 3785 |
|
|
2018
Q4 | – | Sell |
-521
| Closed | -$9K | – | 5782 |
|
|
2018
Q3 | $9K | Buy |
+521
| New | +$9K | ﹤0.01% | 5400 |
|